FDA
-
-
-
-
-
-
-
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates
-
-
-
-
-
-
-
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
-
-
-
-
-
-
-
ADC Therapeutics SA (ADCT) Announces Updated Data from ZYNLONTA Investigator-Initiated Trial R/R Marginal Zone Lymphoma
-
-
-
-
-
-
-
ADC Therapeutics to Present at Upcoming Investor Conferences
-
-
-
-
-
-
-
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
-
-
-
-
-
-
-
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

